Is There a Wegovy 50mg Dose?

No 50mg strength of Wegovy exists in the UK — the highest licensed maintenance dose is 7.2mg, approved by the MHRA in January 2026 and available as a dedicated single-dose pen since April 2026.
Wegovy's titration starts at 0.25mg and moves upward in stages over roughly sixteen to twenty weeks, with a prescriber deciding the pace based on tolerability.
Products labelled with doses far outside the licensed range are a known counterfeit warning sign, the MHRA has seized large quantities of fake weight-loss pens sold online.
Semaglutide at any dose is a prescription-only medicine in the UK; a qualified prescriber must assess your suitability before any treatment begins.

There is no 50mg dose of Wegovy. The highest strength approved in the UK is 7.2mg, reached after a gradual titration that starts at 0.25mg and works up over several months. If you have seen "Wegovy 50mg" mentioned online, it is almost certainly a labelling error, a counterfeit product, or content written about a different medicine entirely. Wegovy (semaglutide) is a prescription-only medicine licensed in the UK for weight management in adults, and its licensed dose range sits well below 50mg — understanding what the real schedule looks like matters, both for safety and for knowing what to expect from treatment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the real Wegovy dose schedule looks like, and why the 50mg figure is a red flag

Where does the "50mg" figure come from?

It crops up most often in two places: social media posts that confuse milligrams with micrograms, and listings from unverified online sellers. Neither source is reliable for medical information. A handful of search queries also conflate Wegovy with Rybelsus, an oral semaglutide tablet licensed for type 2 diabetes, Rybelsus goes up to 14mg, still nowhere near 50mg, and it is not a weight-loss medicine under UK licensing.

Some posts appear to reference dosing units from clinical trial protocols or US-market products in ways that get garbled in translation. Whatever the origin, 50mg is not a dose that appears anywhere in Wegovy's UK Summary of Product Characteristics. If you have come across a seller advertising it at that strength, the MHRA's guidance is clear: medicines sold without a valid prescription through unverified channels carry serious safety risks, including the possibility that the product contains no active ingredient at all, or the wrong one. You can report suspect sellers directly through the MHRA Yellow Card scheme.

The safe starting point is always a licensed pharmacy you can verify on the GPhC register, supplying medicine through the authorised UK supply chain.

What doses of Wegovy are actually licensed in the UK?

Wegovy's approved titration schedule begins at 0.25mg per week for the first four weeks. From there, a prescriber typically steps the dose up through 0.5mg, 1.0mg, and 1.7mg before reaching the standard 2.4mg maintenance dose. Each step lasts roughly four weeks, though the pace is guided by how well you are tolerating treatment rather than by a fixed calendar.

The 2.4mg dose was the established ceiling until January 2026, when the MHRA approved a higher 7.2mg maintenance dose. A dedicated single-dose 7.2mg pen followed in April 2026, designed for adults with a BMI of 30 or above. That pen uses a built-in, auto-dosing mechanism with a covered needle that locks after use. Titration to 7.2mg still begins from the same 0.25mg starting point.

Trial data reported around 20.7% average weight loss at 7.2mg over 72 weeks, narrowing the gap with tirzepatide results. For a closer look at what the 7.2mg step involves and how it fits into the broader schedule, our Wegovy 2 page covers that stage of treatment in detail. If you are curious about what the earlier steps of the schedule feel like in practice, our Wegovy 1 page explains how the treatment begins and what those initial doses typically involve, and the 1.0mg dose page explains what that stage of titration typically involves.

Specific dose availability is confirmed at the point of consultation, a prescriber assesses which step is right for you rather than supply being assumed.

Could a "50mg" product be Wegovy under a different name?

Unlikely. Semaglutide, the active ingredient in Wegovy, is also sold as Ozempic (for type 2 diabetes) and Rybelsus (oral tablets, also diabetes). Neither reaches 50mg. Zepbound is the US brand name for tirzepatide (sold in the UK as Mounjaro) and its highest dose is 15mg. No licensed semaglutide or tirzepatide product anywhere in the world carries a 50mg designation.

If you have been following semaglutide treatment news and stumbled across this figure in a forum or a social media group, it is worth treating it as a prompt to double-check with a prescriber rather than a source to trust. The NHS medicines page for semaglutide sets out the approved doses and what they are licensed for in plain language.

Questions about pricing for genuine Wegovy treatment (what a private prescription actually costs through a regulated service) are answered on our Wegovy cost page, which also explains what legitimate providers include in their pricing.

What should I do if I want to find out whether Wegovy is right for me?

The first step is a clinical assessment with a qualified prescriber. Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea. Ethnic-background thresholds can be lower under UK guidance, a prescriber will work through this with you.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day you submit it. Not software, a clinician who looks at your full picture before any prescription is issued. Orders placed before 12pm on a working day are dispatched the same day once approved, and arrive the next working day via DPD in plain packaging. If your order lands on a Friday afternoon or just before a bank holiday, it will go out the next available working day.

To get a full sense of what the treatment journey looks like from the beginning, our weight loss treatment guide covers how GLP-1 medicines fit into a broader approach. Or if you are ready to find out whether you are eligible, our clinical team at nume is available to review your case. Start your free consultation at our treatment page and a prescriber will be in touch the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions